跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
decapeptide
首页
药物
decapeptide
decapeptide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TYROSINE INHIBITORS WITH IMMUNOSUPPRESSIVE ACTIVITY IN HUMAN NEONATAL KERATINOCYTE PROGENITORS
EP 3911352 A4
申请人: ESCAPE THERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
6 件公开
DEGARELIX ORGANIC SOLVENT FORMULATIONS
EP 4661841 A1
申请人: TOLMAR INTERNATIONAL LTD
优先权: 2023
CN
EP
US
WO
4 件公开
Process for the manufacture of Degarelix and its intermediates
US 9090656 B2
申请人: RASMUSSEN JON HOLBECH
优先权: 2010
EP
US
4 件公开
EP 3981781 A1
申请人: FRESENIUS KABI IPSUM S R L
优先权: 2015
EP
US
3 件公开
US 9260480 B2
申请人: KALITA DIPAK
优先权: 2010
US
2 件公开
Biologically active peptides as glutamate receptor inhibitors
US 2005288231 A1
申请人: LIESI PAIVI
优先权: 2001
US
4 件公开
Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
US 7361349 B2
申请人: PEPSCAN SYSTEMS BV
优先权: 2000
US
3 件公开
DECAPEPTIDE-12 MODULATION OF SIRTUIN GENE EXPRESSION IN EPIDERMAL KERATINOCYTE PROGENITORS
EP 3601316 A4
申请人: ESCAPE THERAPEUTICS INC
优先权: 2017
CN
EP
2 件公开
Method of inhibiting the gonadotropin-releasing hormone (GnRH) receptor by administering a GHR-106 monoclonal antibody
US 11021541 B2
申请人: VANCOUVER BIOTECH LTD
优先权: 2018
CN
US
2 件公开
ENHANCED SKIN PERMEATION OF A NOVEL PEPTIDE VIA STRUCTURAL MODIFICATION, CHEMICAL ENHANCEMENT, AND MICRONEEDLES
US 2023391825 A1
申请人: ESCAPE THERAPEUTICS INC
优先权: 2020
CN
US
2 件公开
NOVEL DECAPEPTIDE AND USE THEREOF IN ANTIBACTERIAL
EP 4725958 A1
申请人: METHYCURE BIOTECH CORP
优先权: 2023
EP
WO
2 件公开
Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase
US 7790171 B1
申请人: CENTRE NAT RECH SCIENT
优先权: 2000
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈